Financials in USD. Standardized financial statements.
A compact view of how Cognetivity Neurosciences Ltd. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $45,366 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth? | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $2.18M | $24,530 | $11,448 | $9,292 | $3,942 | $1,434 | $240 | $10,972 |
| Gross Profit? | -$2.13M | -$24,530 | -$11,448 | -$9,292 | -$3,942 | -$1,434 | -$240 | -$10,972 |
| Gross Margin? | -4694.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $4.16M | $8.96M | $1.28M | $2.61M | $4.21M | $1.49M | $476,799 | $57,676 |
| Operating Income? | -$6.29M | -$13.04M | -$2.39M | -$2.60M | -$4.21M | -$1.49M | -$494,604 | -$82,120.343 |
| EBITDA? | -$6.38M | -$13.01M | -$2.39M | -$2.60M | -$4.21M | -$1.49M | -$494,364 | -$0.343 |
| Income Before Tax | -$7.43M | -$13.13M | -$1.93M | -$2.66M | -$4.19M | -$1.50M | -$458,844 | -$68,648.409 |
| Income Tax Expense | $0 | $0 | $2,285 | -$15,175 | -$21,833 | $1,850 | -$17,955 | $0 |
| Net Income? | -$7.43M | -$13.13M | -$1.93M | -$2.65M | -$4.19M | -$1.50M | -$458,844 | -$68,648.409 |
| EPS? | $-0.09 | $-0.18 | $-0.03 | $-0.06 | $-0.10 | $-0.04 | $-0.01 | $-0.00 |
| Diluted EPS? | $-0.09 | $-0.18 | $-0.03 | $-0.06 | $-0.10 | $-0.04 | $-0.01 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality